Innovations in (Bio)Artificial Organs and Organ Models
Artificial organs are advancing rapidly, presenting both exciting opportunities and complex challenges. As organ failure becomes an increasingly pressing issue, there is an urgent need for innovative solutions that can transform patient care and revolutionize healthcare systems. Breakthroughs in bioartificial organs and organ models are now at the forefront of this transformation, offering new possibilities for medical treatments and patient outcomes. However, to unlock the full potential of these technologies, interdisciplinary collaboration is more critical than ever before. Researchers, clinicians, engineers, and industry leaders must come together to address the challenges and drive progress.
Join ESAO 2025 at the Forefront of Innovation
ESAO 2025 provides an essential platform to foster collaboration and accelerate innovation. Held from June 25 to 28, 2025, at the TechMed Centre, University of Twente (Enschede, The Netherlands), this conference invites experts to explore the latest advancements in bioartificial organs and advanced organ models. This edition, the event is organized by the research group Advanced Organ Bioengineering and Therapeutics (AOT) part of the University of Twente - TechMed Centre, showcasing their leadership and expertise in the field. The event will feature a dynamic program of keynote and plenary presentations, interactive symposia, and discussions, providing in-depth insights into the latest breakthroughs in the field. Attendees will gain valuable knowledge about the potential of bioartificial organs to improve patient care, as well as their ethical and societal implications. By facilitating knowledge exchange and interdisciplinary discussions, ESAO 2025 will empower attendees to explore cutting-edge developments and innovations that are reshaping the future of healthcare.
General information
The programme
Advancing Artificial Organs and Organ Models
ESAO 2025 will showcase research and developments presented by leading researchers, ensuring the program represents the forefront of scientific discovery. The event will emphasize transformative advancements in (bio)artificial heart, lung, kidney, liver, pancreas, and other organs. Multi-organ crosstalk and systems integration will also take center stage, addressing the complexity of interconnected organ functions. Explorations in bioengineering and tissue regeneration will be a key highlight, with a focus on innovative in vitro and in vivo organ models, organs-on-chips, and in silico simulations. Additionally, cutting-edge innovations in biomaterials and surfaces, hemodynamics, biomechanics, imaging, and digital twin technology will drive engaging discussions and collaborative opportunities. By integrating diverse perspectives, ESAO 2025 will inspire progress and redefine possibilities in healthcare innovation.
Confirmed plenary lectures:
A Collaborative Future
ESAO 2025 stands out due to its focus on advancements in research and innovation and its ability to bring together professionals from a wide range of disciplines. Hosted in the world-class facilities of the TechMed Centre, this conference will foster an environment of creativity and innovation. As part of the ESAO organization, the event underscores its commitment to advancing the field of artificial organs and organ models. Additionally, the yESAO will take place on June 24 and 25, 2025, providing a platform for young researchers and early-career professionals to showcase their work and engage with the scientific community. The vibrant city of Enschede and the Twente region further enhance the event, offering a dynamic tech ecosystem and inspiring atmosphere for attendees to connect, collaborate, and build lasting relationships.
ESAO attendees working on artificial kidneys and vascular access may be interested in an additional pre-ESAO single day event that is held on June 24 in the nearby city of Kampen. The Willem Kolff Foundation is organizing a transatlantic celebration of 80 years of hemodialysis (Kolff & van Noordwijk, Kampen 1945) and 65 years of the shunt (Scribner & Quinton, Seattle 1960). The event will not only celebrate the past but also discuss the present state-of-the-art and future perspectives. Also, the Willem Kolff Prize (named after the “Father of Artificial Organs”) will be awarded. ESAO attendees who register for this optional pre-ESAO event will be picked up by a bus in Enschede in the morning and returned to Enschede in the evening.
Registration
Join us at ESAO 2025 to push the frontiers of artificial organ innovation. Together, we will shape the future of healthcare, improve patient outcomes, and advance life-changing technologies. Mark your calendar and be part of this pivotal moment in medical history. Let’s shape the future of healthcare—together.
Organisation
European Society for Artificial Organs (ESAO)
The European Society for Artificial Organs (ESAO) is a scientific society dedicated to the field of artificial organs and organ replacement therapy. This organization aims to promote scientific progress, research, and the application of artificial organs and other technologies in the field of organ substitution.
ESAO provides a platform for the exchange of knowledge and experiences among professionals from various disciplines, including engineers, medical professionals, biologists, and others involved in the research and development of artificial organs. The society regularly organizes conferences, seminars, and workshops where the latest scientific findings are presented and discussed.
Furthermore, ESAO supports collaboration between researchers, clinics, industry, and other organizations to advance translational research and drive innovative technologies in the field of artificial organs.
University of Twente - Advanced Organ Bioengineering and Therapeutics (AOT)
Our mission is to provide innovative technological solutions to patients with chronic and malignant diseases, aiming to improve their quality of life. We are dedicated to educating a new generation of professionals with interdisciplinary knowledge to meet future patient treatment needs.
We achieve our mission by applying cutting-edge technologies at the intersection of chemistry, biomaterials and membrane science, additive manufacturing, fabrication, tissue engineering, and nanomedicine. AOT leverages unique expertise in (bio)artificial organs, targeted therapeutics, biomaterials, and regenerative medicine. Our efforts are integrated into rigorous and interactive training programs for bachelor, master, graduate, and post-graduate students.
We are committed to translating innovative technologies from the laboratory to clinical applications and commercializing our discoveries through the creation of new spin-off companies.
The AOT is a research group that is part of the University of Twente.
Made Possible By
